TCL Archive NCAB Committee Agrees On Seven Characteristics For Comprehensive Centers, Asks For New Division May 12, 1989
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director November 19, 1999
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
